TMEM87a/Elkin1, a component of a novel mechanoelectrical transduction pathway, modulates melanoma adhesion and migration.
cancer biology
cell adhesion
cell biology
cell migration
human
mechanically activated ion channels
mechanotransduction
melanoma
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
01 04 2020
01 04 2020
Historique:
received:
04
11
2019
accepted:
28
03
2020
pubmed:
2
4
2020
medline:
31
3
2021
entrez:
2
4
2020
Statut:
epublish
Résumé
Mechanoelectrical transduction is a cellular signalling pathway where physical stimuli are converted into electro-chemical signals by mechanically activated ion channels. We describe here the presence of mechanically activated currents in melanoma cells that are dependent on TMEM87a, which we have renamed Elkin1. Heterologous expression of this protein in PIEZO1-deficient cells, that exhibit no baseline mechanosensitivity, is sufficient to reconstitute mechanically activated currents. Melanoma cells lacking functional Elkin1 exhibit defective mechanoelectrical transduction, decreased motility and increased dissociation from organotypic spheroids. By analysing cell adhesion properties, we demonstrate that Elkin1 deletion is associated with increased cell-substrate adhesion and decreased homotypic cell-cell adhesion strength. We therefore conclude that Elkin1 supports a PIEZO1-independent mechanoelectrical transduction pathway and modulates cellular adhesions and regulates melanoma cell migration and cell-cell interactions. When cells receive signals about their surrounding environment, this initiates a chain of signals which generate a response. Some of these signalling pathways allow cells to sense physical and mechanical forces via a process called mechanotransduction. There are different types of mechanotransduction. In one pathway, mechanical forces open up specialized channels on the cell surface which allow charged particles to move across the membrane and create an electrical current. Mechanoelectrical transduction plays an important role in the spread of cancer: as cancer cells move away from a tumour they use these signalling pathways to find their way between cells and move into other parts of the body. Understanding these pathways could reveal ways to stop cancer from spreading, making it easier to treat. However, it remains unclear which molecules regulate mechanoelectrical transduction in cancer cells. Now, Patkunarajah, Stear et al. have studied whether mechanoelectrical transduction is involved in the migration of skin cancer cells. To study mechanoelectrical transduction, a fine mechanical input was applied to the skin cancer cells whilst measuring the flow of charged molecules moving across the membrane. This experiment revealed that a previously unknown protein named Elkin1 is required to convert mechanical forces into electrical currents. Deleting this newly found protein caused skin cancer cells to move more slowly and dissociate more easily from tumour-like clusters of cells. These findings suggest that Elkin1 is part of a newly identified mechanotransduction pathway that allows cells to sense mechanical forces from their surrounding environment. More work is needed to determine what role Elkin1 plays in mechanoelectrical transduction and whether other proteins are also involved. This could lead to new approaches that prevent cancer cells from dissociating from tumours and spreading to other body parts.
Autres résumés
Type: plain-language-summary
(eng)
When cells receive signals about their surrounding environment, this initiates a chain of signals which generate a response. Some of these signalling pathways allow cells to sense physical and mechanical forces via a process called mechanotransduction. There are different types of mechanotransduction. In one pathway, mechanical forces open up specialized channels on the cell surface which allow charged particles to move across the membrane and create an electrical current. Mechanoelectrical transduction plays an important role in the spread of cancer: as cancer cells move away from a tumour they use these signalling pathways to find their way between cells and move into other parts of the body. Understanding these pathways could reveal ways to stop cancer from spreading, making it easier to treat. However, it remains unclear which molecules regulate mechanoelectrical transduction in cancer cells. Now, Patkunarajah, Stear et al. have studied whether mechanoelectrical transduction is involved in the migration of skin cancer cells. To study mechanoelectrical transduction, a fine mechanical input was applied to the skin cancer cells whilst measuring the flow of charged molecules moving across the membrane. This experiment revealed that a previously unknown protein named Elkin1 is required to convert mechanical forces into electrical currents. Deleting this newly found protein caused skin cancer cells to move more slowly and dissociate more easily from tumour-like clusters of cells. These findings suggest that Elkin1 is part of a newly identified mechanotransduction pathway that allows cells to sense mechanical forces from their surrounding environment. More work is needed to determine what role Elkin1 plays in mechanoelectrical transduction and whether other proteins are also involved. This could lead to new approaches that prevent cancer cells from dissociating from tumours and spreading to other body parts.
Identifiants
pubmed: 32228863
doi: 10.7554/eLife.53308
pii: 53308
pmc: PMC7173973
doi:
pii:
Substances chimiques
Ion Channels
0
Membrane Proteins
0
PIEZO1 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Health and Medical Research Council
ID : APP1138595
Organisme : National Health and Medical Research Council
ID : APP1135974
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB958, A09
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB958, Z03
Informations de copyright
© 2020, Patkunarajah et al.
Déclaration de conflit d'intérêts
AP, JS, MM, LS, JB, JT, CC, CF, OS, MO, RF, ME, CW, BM, MB, GL, KP No competing interests declared
Références
Oncotarget. 2016 Jul 12;7(28):44630-44643
pubmed: 27329839
DNA Seq. 2007 Jun;18(3):235-41
pubmed: 17454009
Mol Cell Proteomics. 2005 Dec;4(12):1920-32
pubmed: 16127175
Nat Rev Cancer. 2017 Feb;17(2):131-140
pubmed: 27909339
Nat Mater. 2016 Aug;15(8):856-62
pubmed: 27043781
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16124-9
pubmed: 25349433
Cancer Cell. 2005 Sep;8(3):241-54
pubmed: 16169468
Commun Biol. 2019 Aug 7;2:298
pubmed: 31396578
Neuron. 2017 Apr 19;94(2):266-270.e3
pubmed: 28426961
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Nat Rev Neurosci. 2007 Jul;8(7):510-21
pubmed: 17585304
Nucleic Acids Res. 1988 Nov 25;16(22):10881-90
pubmed: 2849754
Exp Cell Res. 2011 May 1;317(8):1119-33
pubmed: 21195710
Pflugers Arch. 2016 Jul;468(7):1197-1206
pubmed: 27023350
Br J Pharmacol. 2018 May;175(10):1744-1759
pubmed: 29498036
Nat Protoc. 2006;1(3):1322-8
pubmed: 17406418
Ultramicroscopy. 2006 Jun-Jul;106(8-9):637-44
pubmed: 16675123
Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10347-52
pubmed: 24958852
Nat Cell Biol. 2018 Jan;20(1):8-20
pubmed: 29269951
Br J Cancer. 2005 Apr 25;92(8):1499-505
pubmed: 15846299
Semin Cell Dev Biol. 2009 Oct;20(8):931-41
pubmed: 19682592
Oncogenesis. 2017 May 22;6(5):e338
pubmed: 28530703
Sci Rep. 2017 Feb 13;7:42369
pubmed: 28205573
Nature. 2014 Nov 13;515(7526):279-282
pubmed: 25119035
Trends Cell Biol. 2016 Jul;26(7):486-497
pubmed: 27056543
Sci Rep. 2016 Jun 13;6:27903
pubmed: 27291497
Sci Rep. 2016 May 17;6:25923
pubmed: 27184818
Proteomics. 2018 Jan;18(1):
pubmed: 29136334
Nat Neurosci. 2011 Jul 03;14(8):993-1000
pubmed: 21725315
Nature. 2012 Feb 19;483(7388):176-81
pubmed: 22343900
Nat Commun. 2017 Nov 27;8(1):1797
pubmed: 29176668
Cell Rep. 2016 May 17;15(7):1430-1441
pubmed: 27160899
Nat Commun. 2018 Mar 15;9(1):1096
pubmed: 29545531
Front Bioeng Biotechnol. 2019 Mar 22;7:47
pubmed: 30984749
Nat Methods. 2010 Dec;7(12):969-71
pubmed: 21076420
Methods Mol Biol. 2014;1156:67-77
pubmed: 24791982
Nat Commun. 2014 Mar 24;5:3520
pubmed: 24662763
Semin Cell Dev Biol. 2017 Nov;71:3-12
pubmed: 28676421
Science. 2010 Oct 1;330(6000):55-60
pubmed: 20813920
J Biol Chem. 2014 Jun 6;289(23):16565-75
pubmed: 24759099
Elife. 2017 Jan 30;6:
pubmed: 28135189
Nat Commun. 2015 Sep 21;6:8329
pubmed: 26387913
Nat Commun. 2013;4:1884
pubmed: 23695678
Nature. 2014 May 29;509(7502):617-21
pubmed: 24717432
Cancer Inform. 2015 Feb 09;14(Suppl 3):1-13
pubmed: 25698877
Nature. 2019 Sep;573(7773):225-229
pubmed: 31435011
Nature. 1999 Apr 1;398(6726):436-41
pubmed: 10201375
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):E1617-E1626
pubmed: 28196892
Cancer Cell. 2011 Aug 16;20(2):229-45
pubmed: 21840487
Mol Biol Cell. 2015 Sep 1;26(17):3071-84
pubmed: 26157166
Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):881-6
pubmed: 23277584
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Proc Natl Acad Sci U S A. 2018 Feb 20;115(8):1925-1930
pubmed: 29432180